Stock DTIL PRECISION BIOSCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Precision BioSciences, Inc.

Equities

DTIL

US74019P2074

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
9.72 USD -1.02% Intraday chart for Precision BioSciences, Inc. -9.33% -11.23%
Apr. 16 Precision BioSciences Opts to Regain Rights to 3 Programs From Eli Lilly Unit Collaboration MT
Apr. 16 Transcript : Precision BioSciences, Inc. - Special Call

Evolution of the average Target Price on Precision BioSciences, Inc.

Price target over the last 5 years

History of analyst recommendation changes

f6b727d35de27f8.zm2ZhjrRBvIES3khoGjiQtVofkoIY1i_dQfdeVI1fto.gDz98la0SIcpHhQY0guBOuwlKwVSVAfePVi7MBpSH4yeFPXTeOIwmV4tNA~f7e56795ff095001f4b40761aca92490

Analyst Recommendations on Precision BioSciences, Inc.

HC Wainwright Adjusts Price Target on Precision BioSciences to $3 From $5, Keeps Buy Rating MT
Precision BioSciences Reports 'High Response Rates' in New Interim Data on Lead Drug Candidate MT
BMO Capital Downgrades Precision BioSciences to Market Perform From Outperform, Adjusts Price Target to $4 From $7 MT
Goldman Sachs Adjusts Price Target on Precision BioSciences to $1 From $2, Maintains Neutral Rating MT
HC Wainwright Lowers Price Target on Precision BioSciences to $17 from $20, Keeps Buy Rating MT
Stifel Nicolaus Adjusts Precision BioSciences Price Target to $9 From $11, Maintains Buy Rating MT
Goldman Sachs Adjusts Precision BioSciences' Price Target to $2 From $3, Keeps Neutral Rating MT
BMO Capital Initiates Precision BioSciences With Outperform Rating, $7 Price Target MT
ECB's rate hike spooks investors Our Logo
ANALYST RECOMMENDATIONS : HubSpot, Target, Tesla, 3M, MongoDB... Our Logo
William Blair Downgrades Precision BioSciences to Market Perform From Outperform MT
Goldman Sachs Adjusts Precision BioSciences' Price Target to $5 from $12, Keeps Neutral Rating MT
BTIG Adjusts Precision BioSciences' Price Target to $20 From $16, Reiterates Buy Rating MT
PRECISION BIOSCIENCES : SMBC Nikko Initiates Coverage on Precision BioSciences With Neutral Rating, $14 PT MT
PRECISION BIOSCIENCES : Stifel Nicolaus Adjusts Precision BioSciences PT to $26 From $23, Maintains Buy Rating MT
PRECISION BIOSCIENCES : JonesTrading Initiates Coverage on Precision BioSciences at Buy Rating, Sets Price Target at $27 MT
PRECISION BIOSCIENCES : JP Morgan Adjusts Price Target for Precision BioSciences to $14 From $10, Maintains Neutral Rating MT
PRECISION BIOSCIENCES : JPMorgan Downgrades Precision BioSciences to Neutral From Overweight, Adjusts Price Target to $10 From $18 MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
9.72 USD
Average target price
35.8 USD
Spread / Average Target
+268.31%
High Price Target
60 USD
Spread / Highest target
+517.28%
Low Price Target
25 USD
Spread / Lowest Target
+157.20%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Precision BioSciences, Inc.

HC Wainwright
BMO Capital
Goldman Sachs
Stifel Nicolaus
William Blair & Co.
BTIG
SMBC Nikko
J.P. Morgan Chase

Ratings for Precision BioSciences, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. DTIL Stock
  4. Consensus Precision BioSciences, Inc.